Oncology Central

Could bioengineered exosome-mimetic nanovesicles be an efficient strategy for the delivery of chemotherapeutics?


The term drug delivery refers to technologies and systems used for controlling the release, absorption and targeting of therapeutic drugs to specific diseased regions, reducing the adverse effects of therapeutics. Because drug delivery systems can increase both the efficacy and the commercial value of therapeutics, drug delivery technology has been the focus of significant scientific and industrial advances. Most of the effort has been aimed at developing nano-sized particles for targeted drug delivery systems.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.